|
|
|
|
Dusa 2004 page 21
author: Tracey Watt
duplicates:
http://www.dusapharma.com/pdf/DUSA_10K_04.pdf
|
|
|
SkyePharma | Solaraze®
- PRODUCT: SOLARAZE ® PARTNER: BRADLEY PHARMACEUTICALS INC/SHIRE Solaraze ® is a topical treatment for a common dermatological condition, actinic keratosis.
This is an increasingly common pre-cancerous skin condition caused by overexposure to sunlight.
If untreated it can progress to squamous cell carcinoma.
Our proprietary hyaluronic acid gel...
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
|
|
|
http://www.int-med.uiowa.edu/Intranet/Residents/xToDelete/GMedCurricOld/Jan-Jun%2004/actinickeratoses/57.pdf
the general population of women of childbearing age, 3- 4 with levonorgestrel- containing OCs and 6- 8 with desogestrel or gestodene, approaching 1 per 1,000 among new users of thirdgeneration progestins during the first year of use (H Jick et ai, BMJ 2000; 321: 1190; JP Vandenbroucke et ai, N Engl J Med 2001; 344: 1527).
' " ,.,- ;0 ' \ NEW TREATMENTS FOR ACTINIC KERATOSES ~ (f["...
author: floerchingerd [ M68498 ]
duplicates:
http://www.int-med.uiowa.edu/Intranet/Residents/xToDelete/GMedCurricOld/Jan-Jun%2004/ActinicKeratoses/57.pdf
|
|
|
http://www.int-med.uiowa.edu/Intranet/Residents/xToDelete/GMedCurricOld/Jan-Jun%2004/actinickeratoses/57.pdf page 2
author: floerchingerd [ M68498 ]
duplicates:
http://www.int-med.uiowa.edu/Intranet/Residents/xToDelete/GMedCurricOld/Jan-Jun%2004/ActinicKeratoses/57.pdf
|
|
|
Drug Approval Package
Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Solaraze (Diclofenac Sodium) Gel Company:--SkyePharma Inc
Application No.:--21-005 Approval Date:-10/16/2000 Approval Letter(s) - Printed Labeling - Medical Review(s)- Part 1 - Part 2 - Part 3 - Chemistry Review(s) - Pharmacology Review(s)- Part 1 - Part 2 - Statistical...
author: USERNAME
|
|
|
Reference Listed Drug Labeling Approved in August 2001
< td WIDTH="7%" VALIGN="middle" HEIGHT="18" style="font-family: MS Sans Serif; font-size: 8; border-bottom: 1px solid rgb(45,50,108)"> 20-450 S-005 CEREZYME letter - imiglucerase for injection 20-367 S-049 Aug 15 ACIPHEX letter label rabeprazole sodium delayed-release tablets 20-973 S-008 ULTRAM letter label tramadol HCl tablets 20-281 S-029 Aug 16 QUINIDEX letter label quinidine su...
author: USERNAME
|
|
|
Prescription and OTC Drug Product List 6/2002
ACTHAR GEL -D- BC + QUESTCOR PHARMS 40 UNITS/ML N08372 006 JUL DISC -A- @ 40 UNITS/ML N08372 006 JUL DISC DIATRIZOATE SODIUM SOLUTION; ORAL, RECTAL HYPAQUE -D- AMERSHAM HLTH 40% N11386 003 JUL DISC -A- @ 40% N11386 003 JUL DISC DICLOFENAC SODIUM GEL; TOPICAL SOLARAZE -A- + BIOGLAN PHARMA 3% N21005 001 OCT 16, 2000 JUL CAHN -D- + BIOGLAN PHARMA PLC 3% N21005 001 OCT 16,...
|
|
|
December 17, 2001
BioCenturyPart II VOL
The companies plan to begin by year end a pexelizumab Phase III trial in patients undergoing coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB)
Dompe will pay an upfront payment and monthly research funding
Surfaxin is in Phase III testing for RDS and MAS and Phase II trials for ARD
Intergen Co., Purchase, N
(SPHC), Las...
author: BioCentury Publications Inc.
subject: BioCentury
|
|
|
December 17, 2001 page 8
author: BioCentury Publications Inc.
subject: BioCentury
|
|
|
http://www.fda.gov/cder/foi/appletter/2001/21005s1ltr.pdf page 1
|
|
|
Prescription and OTC Drug Product List 3/2001
Prescription and Over-the-Counter Drug Product List - 21st Edition Cumulative Supplement Number 3: January-March 2001 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE ATORVASTATIN CALCIUM CAPSULE; ORAL TABLET; ORAL - ADD - BUTALBITAL; ACETAMINOPHEN; AND CAFFEINE WITH CODEINE LIPITOR - ADD - PHOSPHATE ...
|
|
|
http://www.fda.gov/cder/foi/label/2000/21005lbl.pdf
1 Solaraze O O (diclofenac sodium) Gel, 3% w/ w Prescribing Information DESCRIPTION Solaraze O (diclofenac sodium) Gel, 3%, contains the active ingredient, diclofenac sodium, in a clear, transparent, colorless to slightly yellow gel base
1 g of Solaraze O (diclofenac sodium) Gel contains 30 mg of the active substance, diclofenac...
|
|
|
http://www.fda.gov/cder/foi/label/2000/21005lbl.pdf page 6
|
|
|
http://www.fda.gov/cder/foi/label/2000/21005lbl.pdf page 4
|
|
|
http://www.fda.gov/cder/foi/label/2000/21005lbl.pdf page 3
|
|
|
http://www.fda.gov/cder/foi/label/2000/21005lbl.pdf page 2
|
|
|
http://www.fda.gov/cder/foi/label/2000/21005lbl.pdf page 1
|
|
|
http://www.fda.gov/cder/foi/appletter/2000/21005ltr.pdf page 1
|
|
|
PriceWaterhouseCoopers BioScience Index and Share League May - June 2001
- - - - BioNews BioWeb Companies Products BioReports - - - - - PwC BioScience Index & Share League May to June 2001 - ( View pdf file ) The BioScience Index The PwC BioScience Index highlights the performance of UK bioscience companies compared to the FTSE All-Share Index.
Newly listed companies are assigned the BioScience Index at the end of the month in which the company's...
|
|
|
http://www.bradpharm.com/third%20Quarter%202004%20Earnings%2010-28-04.pdf page 2
|
|
|
PM Society - Advertising Awards 2002 - Craft Award: Hospital Direct Mail
PM Society - PM Society 2002 Advertising Awards - Craft Award: Hospital Direct Mail To Stay up to date with all the PM Society's latest news and events, sign up to the PM Society Update, click here for more..
- Craft Award Hospital Direct Mail - Position Mailing Company Agency WINNER Adept (1.5 litre bag) Shire Pharmaceuticals Swordfish Advertising Commended Celsior Imtix Sangstat...
|
|
|
PM Society - Advertising Awards 2002 - Craft Award: Hospital Journal Advertisement
PM Society - PM Society 2002 Advertising Awards - Craft Award: Hospital Journal Advertisement To Stay up to date with all the PM Society's latest news and events, sign up to the PM Society Update, click here for more..
- Craft Award Hospital Journal Advertisement - Position Advertisement Company Agency WINNER Requip (Toilet) GlaxoSmithKline Junction 11 Advertising Highly Commended...
|
|
|
PM Society - Advertising Awards 2002 - Craft Award: GP Direct Mail
PM Society - PM Society 2002 Advertising Awards - Craft Award: GP Direct Mail To Stay up to date with all the PM Society's latest news and events, sign up to the PM Society Update, click here for more..
- Craft Award GP Direct Mail - Position Mailing Company Agency WINNER Calcichew D3 Forte (Weak bones) Shire Pharmaceuticals Swordfish Advertising Commended Solaraze (Rotting...
|
|
|
Quintiles Transnational Corp. and Subsidiaries page 25
author: Denise M. Wyant
|
